Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction

Journal of the American Geriatrics Society

Volumn 47, Issue 5, 1999, Pages 512-517

  Gillman, Matthew W ^c   Ross Degnan, Dennis ^c   McLaughlin, Thomas J ^c   Gao, Xiaoming ^c   Spiegelman, Donna ^a   Hertzmark, Ellen ^a   Goldman, Lee ^b   Soumerai, Stephen B ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Administrative data; Calcium channel blocker; Cohort study; Myocardial infarction; Older people

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; NICARDIPINE; NIFEDIPINE; VERAPAMIL;

ACUTE HEART INFARCTION; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

EID: 0032909339     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1999.tb02562.x     Document Type: Article

References (23)

1. Psaty BM, Heckbert SR, Koepsell TD et al. The risk of mycoardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-625.
2. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
3. Pahor M, Guralnik JM, Corti MC et al. Long-term survival and use of anti-hypertensive medications in older persons. J Am Geriatr Soc 1995;43:1191-1197.
4. Pahor M, Guralnik JM, Ferrucci L et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996;348:493-497.
5. Pahor M, Guralnik JM, Furberg CD et al. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996;347:1061-1065.
6. Borhani NO, Mercuri M, Borhani PA et al. Final outcome results of the multicenter isradipine diuretic artherosclerosis study (MIDAS). JAMA 1996;276: 785-791.
7. Fitzpatrick AL, Daling JR, Furberg CD et al. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer 1997;80: 1438-1447.
8. Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol 1991;67:1295-1297.
9. Glasser SP, Clark PI, Lipicky RJ et al. Exposing patients with chronic, stable, exertional angina to placebo periods in drug trials. JAMA 1991;265:1550-1554.
10. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial-II-DAVIT II). Am J Cardiol 1990; 66:779-785.
11. Hansen JF, Hagerup L, Sigurd B et al. Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Am J Cardiol 1997;79:738-741.
12. Rengo F, Carbonin P, Pahor M et al. A controlled trial of verapamil in patients after acute myocardial infarction. Results of the Calcium Antagonist Reinfarction Italian Study-CRIS. Am J Cardiol 1996;77:365-369.
13. Ishikawa K, Nakai S, Takenaka T et al. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Circulation 1997;95:2368-2373.
14. Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319:385-392.
15. Kloner RA. Nifedipine in ischemic heart disease. Circulation(editorial). 1995;92:1074-1078.
16. Opie LH, Messerli FH. Nifedipine and mortality. Grave defects in the dossier. Circulation(editorial) 1995;92:1068-1073.
17. Packer M, O'Connor CM, Ghali JK et al. Effect of amlodipine on mobidity and mortality in severe chronic heart failure. N Engl J Med 1996;335:1107-1114.
18. Staessen JA, Fagard R, Thijs L et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-764.
19. Alderman MH, Cohen H, Roque R, Madhavan S. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet 1997;349:594-598.
20. Soumerai SB, McLaughlin TJ, Spiegelman D et al. Adverse outcomes of underuse of beta blockers in elderly survivors of acute myocardial infarction. JAMA 1997;277:115-121.
21. Yusuf S. Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation? Circulation(editorial) 1995;92:1079-1082.
22. Egstrup K, Andersen PE. Transient myocardial ischemia during nifedipine therapy in stable angina pectoris and its relation to coronary collateral flow and comparison with metoprolol. Am J Cardiol 1993;71:177-183.
23. Opie LH. Pharmacological differences between calcium antagonists. Eur Heart J 1997;18:A71-79.